TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  Benzinga

MCTA Investors Have Opportunity to Lead Charming Medical Limited Securities Fraud Lawsuit with the Schall Law Firm

Benzinga Logo Benzinga By Prnewswire
MCTA Investors Have Opportunity to Lead Charming Medical Limited Securities Fraud Lawsuit with the Schall Law Firm

The Schall Law Firm is seeking lead investors for a class action lawsuit against Charming Medical Limited (NASDAQ: MCTA) for securities fraud. The company faced an SEC trading suspension in November 2025 after its stock price spiked dramatically without justification, allegedly due to a promotion scheme involving social media advisors. Investors who purchased securities between October 21-November 12, 2025, are encouraged to join the lawsuit by February 17, 2026.

Insights
FIG   positive

Cloud-based design platform challenging Adobe, with 45% growth in high-value customers and expected revenue CAGR of 27% from 2024 to 2027


MCTA   negative

The company is the subject of a securities fraud lawsuit, faced an SEC trading suspension, and is alleged to have made false and misleading statements to the market. The stock price spike was allegedly driven by a promotion scheme rather than legitimate business developments, resulting in investor losses.